Ke Fang

MOE Key Laboratory Of Gene Function And Regulation, Guangdong Province Key Laboratory Of Pharmaceutical Functional Genes, State Key Laboratory For Biocontrol
Guangzhou, 510275, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

RBM15B recognizes H3K79me2 to guide selective m6A-modification of mRNA and enhance oncoprotein translation in MLL-r leukemia.

RBM15B recognizes H3K79me2 to guide selective m6A-modification of mRNA and enhance oncoprotein translation in MLL-r leukemia.

Journal: The EMBO journal

Published: April 14, 2025

Genome assembly of redclaw crayfish (Cherax quadricarinatus) provides insights into its immune adaptation and hypoxia tolerance.

Genome assembly of redclaw crayfish (Cherax quadricarinatus) provides insights into its immune adaptation and hypoxia tolerance.

Journal: BMC genomics

Published: April 22, 2024

METTL3 protects METTL14 from STUB1-mediated degradation to maintain m6 A homeostasis.

METTL3 protects METTL14 from STUB1-mediated degradation to maintain m6 A homeostasis.

Journal: EMBO reports

Published: July 10, 2022

The snoRNA-like lncRNA LNC-SNO49AB drives leukemia by activating the RNA-editing enzyme ADAR1.

The snoRNA-like lncRNA LNC-SNO49AB drives leukemia by activating the RNA-editing enzyme ADAR1.

Journal: Cell discovery

Published: March 26, 2022

N6-methyladenosine methyltransferases: functions, regulation, and clinical potential.

N6-methyladenosine methyltransferases: functions, regulation, and clinical potential.

Journal: Journal of hematology & oncology

Published: June 11, 2021

Chromatin-associated orphan snoRNA regulates DNA damage-mediated differentiation via a non-canonical complex.

Chromatin-associated orphan snoRNA regulates DNA damage-mediated differentiation via a non-canonical complex.

Journal: Cell reports

Published: May 17, 2021

Correction to: The lncRNA LAMP5-AS1 drives leukemia cell stemness by directly modulating DOT1L methyltransferase activity in MLL leukemia.

Correction to: The lncRNA LAMP5-AS1 drives leukemia cell stemness by directly modulating DOT1L methyltransferase activity in MLL leukemia.

Journal: Journal of hematology & oncology

Published: March 12, 2021

A CRISPR/CAS9-based strategy targets the personalized chimeric neosequence in fusion-driven cancer genome for precision medicine.

A CRISPR/CAS9-based strategy targets the personalized chimeric neosequence in fusion-driven cancer genome for precision medicine.

Journal: Clinical and translational medicine

Published: November 16, 2020

The oncomicropeptide APPLE promotes hematopoietic malignancy by enhancing translation initiation.

The oncomicropeptide APPLE promotes hematopoietic malignancy by enhancing translation initiation.

Journal: Molecular cell

Published: September 03, 2020

The lncRNA LAMP5-AS1 drives leukemia cell stemness by directly modulating DOT1L methyltransferase activity in MLL leukemia.

The lncRNA LAMP5-AS1 drives leukemia cell stemness by directly modulating DOT1L methyltransferase activity in MLL leukemia.

Journal: Journal of hematology & oncology

Published: April 16, 2020

Cis-acting lnc-eRNA SEELA directly binds histone H4 to promote histone recognition and leukemia progression.

Cis-acting lnc-eRNA SEELA directly binds histone H4 to promote histone recognition and leukemia progression.

Journal: Genome biology

Published: April 04, 2020

Nuclear export of chimeric mRNAs depends on an lncRNA-triggered autoregulatory loop in blood malignancies.

Nuclear export of chimeric mRNAs depends on an lncRNA-triggered autoregulatory loop in blood malignancies.

Journal: Cell death & disease

Published: February 06, 2020

Showing 1-12 of 21

Last Updated: 09/26/2026